INTERACTIVE: Arena SVP Audet on steady Belviq sales progress
This article was originally published in Scrip
Executive Summary
Sales gains for the Arena Pharmaceuticals prescription weight loss drug Belviq (lorcaserin) have been slow since the product's launch in mid-2013 considering the millions of people who are considered overweight and obese in the US, but Belviq sales have increased by double digits from quarter to quarter.